Current status and future directions in standardization of prostate- specific antigen immunoassay

Urology

Volumn 51, Issue 5 SUPPL. A, 1998, Pages 83-88

  Nakamura, Robert M ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Natl Comm Clin Lab Std (NCCLS)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; GAMMA SEMINOPROTEIN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; HUMAN; IMMUNOASSAY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; STANDARDIZATION;

DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOASSAY; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REFERENCE STANDARDS;

EID: 0031806414     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00079-X     Document Type: Article

References (44)

1. Hara H., KoyanagI Y., Inoue T., Fukuyama T. Some physicochemical characteristics of gamma-seminoprotein an antigenic component specific for human seminal plasma . Jpn J Legal Med. 25:1971;322-324.
2. Sensabaugh G.F. Isolation and characterization of a semen-specific protein from human seminal plasma a potential new marker for semen identification . J Forensic Sci. 23:1978;106-115.
3. Wang M.C., Valenzuela L.A., Murphy G.P., Chu T.M. Purification of a human prostate specific antigen. Invest Urol. 17:1979;159-163.
4. Wang M.C., Papsidero L.D., Kuriyama M., Valenzuela L.A., Murphy G.P., Chu T.M. Prostate antigen a new potential marker for prostatic cancer . Prostate. 2:1981;89-96.
5. Stamey T.A., Yang N., Hay A.R., McNeal J.E., Freiha F.S., Redwine E. Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 317:1987;909-916.
6. Oesterling J.E. Prostate specific antigen a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate . J Urol. 145:1991;907-923.
7. Gittes R.F. Carcinoma of the prostate. N Engl J Med. 324:1991;236-245.
8. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer assay of the complex improves clinical sensitivity for cancer . Cancer Res. 51:1991;222-226.
9. 1-antichymotrypsin. Clin Chem. 37:1991;1618-1625.
10. 1-antichymotrypsin in blood implications for procedures to measure prostate-specific antigen in serum . Cancer. 70:(suppl):1992;230-234.
11. 1-antichymotrypsin as an indicator of prostate cancer. J Urol. 150:1993;100-105.
12. Oesterling J.E., Chan D.W., Epstein J.I., Kimball A.W., Bruzek D.J., Rock R.C., Brendler C.B., Walsh P. Prostate-specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol. 139:1988;766-772.
13. Christensson A., Laurell C.B., Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem. 194:1990;755-763.
14. Papsidero L.D., Kuriyama M., Wang M.C., Horoszewicz J.S., Leong S.S., Valenzuela L.A., Murphy G.P., Chu T.M. Prostate antigen a marker for human prostate epithelial cell . J Natl Cancer Inst. 66:1981;37-41.
15. Wu J.T. Assay for prostate-specific antigen (PSA) problems and possible solutions . J Clin Lab Anal. 8:1994;51-62.
16. Sensabaugh G.F., Blake E.T. Seminal plasma protein p30 simplified purification and evidence for identity with prostate-specific antigen . J Urol. 144:1990;1523-1526.
17. Mettlin C., Jones G., Averette H., Gusberg S., Murphy G.P. Defining and updating the American Cancer Society guidelines for the cancer-related check-up prostate and endometrial cancer . CA Cancer J Clin. 43:1993;42-46.
18. 1-antichymotrypsin. Clin Chem. 39:1993;2098-2103.
19. Graves H.C.B. Standardization of immunoassays for prostate-specific antigen a problem of prostate-specific antigen complexation or a problem of assay design? Cancer. 72:1993;3141-3144.
20. Stephenson R.A., Greskovich F.J., Fritsche H.A., James B.C. Ratio of polyclonal-monoclonal prostate specific antigen levels discrimination of nodal status in prostate tumors that produce low marker levels . Urol Clin North Am. 18:1991;467-471.
21. Chan D.W., Bruzek D.J., Oesterling J.E., Rock R.C., Walsh P.C. Prostate-specific antigen as a marker for prostatic cancer a monoclonal and a polyclonal immunoassay compared . Clin Chem. 33:1987;1916-1920.
22. Horton G.L., Bahnson R.R., Daft M., Chan K.M., Catalona W.J., Ladenson J.H. Differences in values obtained with two assays of prostate-specific antigen. J Urol. 139:1988;762-772.
23. Graves H.C.B., Wehner N., Stamey T.A. Comparison of a polyclonal and monoclonal immunoassay for PSA need for an international antigen standard . J Urol. 144:1990;1516-1522.
24. Graves H.C.B. Issues on standardization of immunoassays for prostate-specific antigen a review . Clin Invest Med. 16:1993;415-424.
25. Rippey J.H., Wener M.H., Horoszewicz J., Stenman U.H., Klee G.G., Belanger A., Maxim P.E., Graves H., Howanitz J., Nakamura R.M. Work group 1 standardization of PSA . Cancer. 71:1993;2678-2680.
26. Garg U.C., Howanitz J.H., Nakamura R.M., Plous R.H., Eckfeldt J.H. Production, analysis and characterization of reference materials for prostate-specific antigen. Arch Pathol Lab Med. 119:1995;1104-1108.
27. Stamey T.A., Prestigiacomo A.F., Chen Z. Standardization of immunoassays for prostate-specific antigen a different view based on experimental observations . Cancer. 74:1994;1662-1666.
28. Zhou A.M., Tweari P.C., Bluestein B.L., Caldwell G.W., Larsen F.L. Multiple forms of prostate-specific antigen in serum differences in immunorecognition by monoclonal and polyclonal assays . Clin Chem. 12:1993;2483-2491.
29. Murphy G.P. The second Stanford conference on international standardization of prostate-specific antigen assays. Cancer. 75:1995;122-128.
30. Stamey T.A. Second Stanford conference on international standardization of prostate-specific antigen immunoassays September 1 and 2, 1994 . Urology. 45:1995;173-184.
31. 1-antichymotrypsin international standardization of PSA immunoassays . Clin Chem. 41:1995;1273-1282.
32. 1-antichymotrypsin complex . Clin Chem. 41:1995;1480-1488.
33. 1-antichymotrypsin before diagnosis of prostate cancer. Lancet. 344:1994;1594-1598.
34. Catalona W.J., Smith D.S., Wolfert R.L., Wang T.J., Rittenhouse H.G., Ratliff T.L., Nader R.B. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA. 274:1995;1214-1220.
35. Nakamura R.M. Current and future directions regarding quality assurance and standardization of prostate specific antigen immunoassays. Cancer. 74:1994;1655-1659.
36. Sokoloff R., Wolfert R.L., Rittenhouse H.G. Standardization of PSA immunoassays proposals and limitations . J Clin Ligand Assay. 18:1995;86-92.
37. Graves H.C.B. Issues on standardization of immunoassays for prostate-specific antigen a review . Clin Invest Med. 16:1993;415-424.
38. Graves H.C.B. Progress towards PSA assay standards. Cockett A.T.K., Khoury S., Aso Y., Chatelain C., Denis L., Griffiths K., Murphy G. Proceedings of the Third International Consultation on Benign Prostate Hyperplasia (BPH), June 26-28, 1995. 1995;Scientific Communications Int. (SCI), Channel Islands.
39. Demura T., Watarai Y., Togashi M., Hirano T., Ohashi N., Koyanagi T. Measurement of prostate-specific antigen and gamma-seminoprotein ratio a new means of distinguishing benign prostatic hyperplasia and prostate cancer . J Urol. 150:1993;1740-1745.
40. Wu J.T., Wilson L., Zhang P., Meikle A.W., Stephenson R. Correlation of serum concentrations of PSA-ACT complex with total PSA in random and serial specimens from patients with BPH and prostatic cancer. J Clin Lab Anal. 9:1995;15-24.
41. Graves H.C.B., Wehner N., Stamey T.A. Ultrasensitive radioimmunoassay of prostate-specific antigen. Clin Chem. 38:1992;735-742.
42. Liedtke R.J., Kroon G., Ratjer J.D. Modified assay of prostate-specific antigen with a detection limit <0.01 μg/l. Clin Chem. 39:1993;2150-2154.
43. Yu H., Diamandis E.P. Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies. Clin Chem. 39:1993;2108-2114.
44. Vessella R.L. Trends in immunoassays of prostate-specific antigen serum complexes and ultrasensitivity . Clin Chem. 39:1993;2035-2039.